| Dr Pheonix Ellis Sinclair, DDS | |
|
4140 Mother Lode Dr, Suite 112, Shingle Springs, CA 95682-8038 | |
| (530) 672-8059 | |
| (530) 672-2111 |
| Full Name | Dr Pheonix Ellis Sinclair |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 4140 Mother Lode Dr, Shingle Springs, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952450686 | NPI | - | NPPES |
| THP70630F | Medicaid | CA | |
| D25841 | Other | CA | DENTAL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | D25841 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Pheonix Ellis Sinclair, DDS 3335 Rolls Dr, Cameron Park, CA 95682-9246 Ph: (530) 676-7197 | Dr Pheonix Ellis Sinclair, DDS 4140 Mother Lode Dr, Suite 112, Shingle Springs, CA 95682-8038 Ph: (530) 672-8059 |
News Archive
The Kenyan government recently signed an agreement for a grant worth 1.1 billion shillings, or about $15 million, for the fight against HIV/AIDS, Kenya's Nation reports.
Hospital officials in Washington state have apologized after failing for months to inform a pregnant woman she was likely infected with the Zika virus that can cause devastating birth defects.
The discovery of long non-coding RNA (lncRNA) has dramatically changed the understanding of the biology of diseases such as cancer. The human genome contains about 20,000 protein-coding genes - less than 2 percent of the total - but 70 percent of the genome is made into non-gene-encoding RNA.
MicroStockProfit.com announces an investment report featuring BioSphere Medical Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
CytoDyn Inc., a biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses, announced today that the Company has submitted a Phase 2b clinical trial protocol, for its lead product candidate, PRO 140, to the U.S. Food and Drug Administration for treatment substitution in patients with Human Immunodeficiency Virus (HIV).
› Verified 4 days ago
Erik M Matson, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 3591 Vista Grande Dr, Shingle Springs, CA 95682 Phone: 619-920-4696 | |
Donald William Stoneburner, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 4140 Mother Lode Dr, Suite 112, Shingle Springs, CA 95682 Phone: 530-672-8059 Fax: 530-672-2111 |